Skip to main
MYO
MYO logo

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc. has demonstrated a robust growth trajectory in its reimbursement pipeline, which increased to 1,611 units from 1,482 in Q1 and 1,389 in Q4 of the previous year. This upward trend indicates a strengthening demand for its myoelectric orthotics and highlights the company's expanding market presence, particularly in the orthotics and prosthetics sector. Additionally, the recent Medicare ruling by the CMS to include MyoPro under Medicare Part B benefits significantly broadens the company's potential market, aligning it with a large and crucial revenue stream.

Bears say

Myomo Inc has revised its 2025 revenue guidance downward to a range of $40 – 42 million, significantly lower than the previously anticipated $50 – 53 million. The company's marketing and pipeline performance have also underperformed, leading to decreased lead quality and conversion rates. Additionally, the backlog of insurance-authorized orders has declined to 230, down from 249 in the previous quarter and 272 at the end of the prior fiscal year.

Myomo (MYO) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.